Ivabradine sustained-release - Jiangsu Hengrui Medicine Co.Alternative Names: Ivabradine hemisulfate sustained-release tablets - Jiangsu HengRui Medicine
Latest Information Update: 24 Nov 2015
Price : $50
At a glance
- Originator Jiangsu Hengrui Medicine Co.
- Class Benzazepines; Bradycardic agents; Heterocyclic bicyclo compounds; Ischaemic heart disorder therapies; Small molecules
- Mechanism of Action Potassium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II/III Chronic heart failure